Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU

The latest advances in pharmaceutical technology are leading to the development of cutting edged approaches to produce what is now known as the “Holy Grail” of medicine—nanopharmaceutics. Over the latest decade, the pharmaceutical industry has made important contributions to the scale up of these ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Souto, Eliana B., Silva, Gabriela F., Dias-Ferreira, João, Zielinska, Aleksandra, Ventura, Fátima, Durazzo, Alessandra, Lucarini, Massimo, Novellino, Ettore, Santini, Antonello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076491/
https://www.ncbi.nlm.nih.gov/pubmed/32053962
http://dx.doi.org/10.3390/pharmaceutics12020146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076491/
https://www.ncbi.nlm.nih.gov/pubmed/32053962
http://dx.doi.org/10.3390/pharmaceutics12020146

Ejemplares similares